Skip to content

Breaking News

SUBSCRIBER ONLY

Drugs like Ozempic linked to lower cancer risk in study

On Oct. 23, 2023, Ozempic medication boxes, an injectable antidiabetic drug, in a pharmacy in Riedisheim, France.
On Oct. 23, 2023, Ozempic medication boxes, an injectable antidiabetic drug, in a pharmacy in Riedisheim, France.
UPDATED:

Blockbuster weight loss and diabetes drugs may lower patients’ risk of developing some common types of cancer that are closely linked to obesity, new evidence suggests. Patients with Type 2 diabetes who were prescribed drugs known as glucagon-like peptide-1, or GLP-1, developed fewer obesity-related cancers than patients who were treated with insulin, according to a study published Friday in …

Subscribe to continue reading this article.

Already subscribed? To login in, click here.

Originally Published: